With the aim of determining if lower plasma NGB levels are associated with a higher risk of developing dementia, we carried out a pilot longitudinal study to determine the NGB levels from plasma of healthy donors drawn the first visit (V1) and 5 years later (V5), when some of them had developed different degrees of cognitive impairment (see Table 1). Here, NGB is linked to dementia.